Definium Therapeutics, Inc. Operating Income
Definium Therapeutics, Inc. (DFTX) reported Operating Income of -$75.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Definium Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$75.08M.
- Definium Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$59.22M.
- Definium Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$47.58M.
- Definium Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$45.67M.
- Definium Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$166.31M.
- Definium Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$103.92M.
- Definium Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$93.87M.
- Definium Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$66.33M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 7 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$75.08M 10-Q · filed 2026-08-06 | -$134.30M 10-Q · filed 2026-08-06 | -$181.88M derived: sum of 3 quarters · filed 2026-08-06 | -$227.54M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$59.22M 10-Q · filed 2026-05-07 | -$106.80M derived: sum of 2 quarters · filed 2026-05-07 | -$152.47M derived: sum of 3 quarters · filed 2026-05-07 | -$193.37M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$47.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$93.25M derived: sum of 2 quarters · filed 2026-02-26 | -$134.15M derived: sum of 3 quarters · filed 2026-08-06 | -$166.31M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$45.67M 10-Q · filed 2025-11-06 | -$86.57M derived: sum of 2 quarters · filed 2026-08-06 | -$118.73M 10-Q · filed 2025-11-06 | -$151.19M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$40.90M 10-Q · filed 2026-08-06 | -$73.06M 10-Q · filed 2026-08-06 | -$105.52M derived: sum of 3 quarters · filed 2026-08-06 | -$130.32M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$32.16M 10-Q · filed 2026-05-07 | -$64.62M derived: sum of 2 quarters · filed 2026-05-07 | -$89.41M derived: sum of 3 quarters · filed 2026-05-07 | -$113.87M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$32.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$57.25M derived: sum of 2 quarters · filed 2026-02-26 | -$81.71M derived: sum of 3 quarters · filed 2026-02-26 | -$103.92M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$24.79M 10-Q · filed 2025-11-06 | -$49.25M derived: sum of 2 quarters · filed 2025-11-06 | -$71.45M 10-Q · filed 2025-11-06 | -$93.66M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$24.46M 10-Q · filed 2025-07-31 | -$46.66M 10-Q · filed 2025-07-31 | -$68.87M derived: sum of 3 quarters · filed 2025-07-31 | -$90.48M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | -$22.20M 10-Q · filed 2025-05-08 | -$44.41M derived: sum of 2 quarters · filed 2025-05-08 | -$66.03M derived: sum of 3 quarters · filed 2025-05-08 | -$95.21M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$22.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$43.82M derived: sum of 2 quarters · filed 2025-03-06 | -$73.00M derived: sum of 3 quarters · filed 2025-03-06 | -$93.87M 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$21.62M 10-Q · filed 2024-11-07 | -$50.80M derived: sum of 2 quarters · filed 2024-11-07 | -$71.66M 10-Q · filed 2024-11-07 | -$85.56M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$29.18M 10-Q · filed 2024-08-13 | -$50.05M 10-Q · filed 2024-08-13 | -$63.95M derived: sum of 3 quarters · filed 2024-08-13 | -$80.93M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$20.86M 10-Q · filed 2024-05-08 | -$34.76M derived: sum of 2 quarters · filed 2024-05-08 | -$51.74M derived: sum of 3 quarters · filed 2024-05-08 | -$68.69M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | -$13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$30.88M derived: sum of 2 quarters · filed 2024-02-28 | -$47.83M derived: sum of 3 quarters · filed 2024-02-28 | -$66.33M 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$16.98M 10-Q · filed 2023-11-02 | -$33.93M derived: sum of 2 quarters · filed 2023-11-02 | -$52.43M 10-Q · filed 2023-11-02 | -$69.99M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | -$16.94M 10-Q · filed 2023-08-03 | -$35.45M 10-Q · filed 2023-08-03 | -$53.01M derived: sum of 3 quarters · filed 2023-08-03 | -$70.23M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$18.50M 10-Q · filed 2023-05-04 | -$36.06M derived: sum of 2 quarters · filed 2023-05-04 | -$53.29M derived: sum of 3 quarters · filed 2023-05-04 | -$98.51M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | -$17.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$34.78M derived: sum of 2 quarters · filed 2023-03-09 | -$80.00M derived: sum of 3 quarters · filed 2023-03-09 | -$93.85M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$17.23M 10-Q · filed 2022-11-10 | -$62.45M derived: sum of 2 quarters · filed 2022-11-10 | -$76.30M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$45.22M 10-Q · filed 2022-08-11 | -$59.07M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | -$13.85M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | -$33.03M 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | -$10.73M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |